Publicaciones en las que colabora con Eduardo Martín Sanz (20)

2024

  1. Clinical practice guideline on the management of vestibular schwannoma

    Acta Otorrinolaringologica Espanola, Vol. 75, Núm. 2, pp. 108-128

2022

  1. Low-Dose Intratympanic Gentamicin for Unilateral Ménière‘s Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome

    Frontiers in Neurology, Vol. 13

2020

  1. Oscillopsia in Bilateral Vestibular Hypofunction: Not Only Gain But Saccades Too

    Ear and hearing, Vol. 41, Núm. 2, pp. 323-329

  2. Relevance of Artifact Removal and Number of Stimuli for Video Head Impulse Test Examination

    Ear and Hearing, Vol. 41, Núm. 5, pp. 1397-1406

2019

  1. Delayed Effect and Gain Restoration after Intratympanic Gentamicin for Menière's Disease

    Otology and Neurotology, Vol. 40, Núm. 1, pp. 79-87

2018

  1. Analysis of scientific production in otolaryngology in Spain in the period 2011-2015

    Acta Otorrinolaringologica Espanola, Vol. 69, Núm. 5, pp. 275-282

2017

  1. Extended phenotype and clinical subgroups in unilateral Meniere disease: A cross-sectional study with cluster analysis

    Clinical Otolaryngology, Vol. 42, Núm. 6, pp. 1172-1180

  2. Regulation of Fn14 receptor and NF-κB underlies inflammation in Meniere's disease

    Frontiers in Immunology, Vol. 8, Núm. DEC

2016

  1. Clinical subgroups in bilateral meniere disease

    Frontiers in Neurology, Vol. 7, Núm. OCT

  2. Therapeutic illusion: Another frontier in Ménière's disease

    Annals of Translational Medicine

2014

  1. Intronic variants in the NFKB1 gene may influence hearing forecast in patients with unilateral sensorineural hearing loss in meniere's disease

    PLoS ONE, Vol. 9, Núm. 11

2005

  1. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease

    Audiology and Neurotology, Vol. 10, Núm. 2, pp. 69-78

2004

  1. Intratympanic gentamicin in patients with Ménière's disease: analysis of our protocol

    Acta Otorrinolaringologica Espanola, Vol. 55, Núm. 6, pp. 270-276

2003

  1. Dizziness: Relating the severity of vertigo to the degree of handicap by measuring vestibular impairment

    Otolaryngology - Head and Neck Surgery, Vol. 128, Núm. 3, pp. 372-381

  2. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease

    Otology and Neurotology, Vol. 24, Núm. 5, pp. 800-806

  3. Intratympanic gentamicin for intractable Meniere's disease

    Laryngoscope, Vol. 113, Núm. 3, pp. 456-464

  4. Results of vestibular autorotation testing at the end of intratympanic gentamicin treatment for Ménière's disease

    Acta Oto-Laryngologica, Vol. 123, Núm. 4, pp. 506-514

2002

  1. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin

    Laryngoscope, Vol. 112, Núm. 6, pp. 1104-1109

2001

  1. Factor analysis and correlation between Dizziness Handicap Inventory and Dizziness Characteristics and Impact on Quality of Life Scales

    Acta Oto-Laryngologica, Supplement

  2. Influence of canal paresis and compensation on gain and time constant of nystagmus slow-phase velocity to yaw-axis rotation

    Acta Oto-Laryngologica, Vol. 121, Núm. 6, pp. 715-723